SenesTech, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SenesTech, Inc. on June 2, 2017. The filing reports the appointment of a new senior executive officer and details the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Base Salary: $300,000 annually.
- Signing Bonus: 60,000 restricted stock units (RSUs) vesting quarterly over 3 years.
- Target Incentive Bonus: 100% of base salary ($300,000), payable 30% in cash and 70% in equity.
- Relocation Benefits: Up to $30,000 for moving expenses and up to $2,000 per month for rental allowance for six months.
Material Changes
On June 2, 2017, the Company announced the appointment of Andrew Altman as Chief Operations Officer and Executive Vice President, with an anticipated start date of June 19, 2017. Mr. Altman joins from Idexx BioResearch, where he served as Vice President and General Manager from 2012 to 2017.
Outlook, Risks, and Contingencies
The employment agreement includes specific provisions regarding termination and change in control:
- Acceleration of Equity: 100% of unvested equity awards immediately vest upon a Change in Control, termination by the Company without Cause, or termination by Mr. Altman for Good Reason.
- Good Reason Definition: Includes material reduction in salary/benefits, material diminution of job duties, or a change in employment location of more than 50 miles.
- Cure Period: The Company has 30 days to cure grounds for "Good Reason" after receiving written notice from Mr. Altman.
Investor Verification Checklist
- Verify the impact of the new executive leadership on operational strategy and product development timelines.
- Review the Company's 2015 Equity Incentive Plan to understand the dilution impact of the 60,000 RSUs and future bonus grants.
- Confirm the Company's cash position to ensure it can meet the immediate signing bonus obligations and ongoing salary commitments.
- Monitor future filings for updates on Mr. Altman's actual start date and any subsequent changes to the compensation structure.